RGDs registry under the 'Cardiovascular disorders'
| Disorder Name (Total=23) | Aliases | Sub-Category | Gene | Indian Reports | Link |
|---|---|---|---|---|---|
| Tetralogy of Fallot Autosomal dominant |
•Fallot tetralogy |
Congenital heart disease |
JAG1 jagged canonical Notch ligand 1 NKX2-5 NK2 homeobox 5 GATA4 GATA binding protein 4 GATA6 GATA binding protein 6 ZFPM2 zinc finger protein, FOG family member 2 EPHB4 EPH receptor B4 NOTCH1 notch receptor 1 TPM1 tropomyosin 1 TBX1 T-box transcription factor 1 NIPBL NIPBL cohesin loading factor MT-CO1 mitochondrially encoded cytochrome c oxidase I MT-CO2 mitochondrially encoded cytochrome c oxidase II MT-CO3 mitochondrially encoded cytochrome c oxidase III ROBO1 roundabout guidance receptor 1 FLNC filamin C |
Reports Updated as of Dec 29, 2023 |
PubMed |
| Takayasu arteritis |
•Aortic arch syndrome |
Arterial disorders |
MLXIPL MLX interacting protein like IL12B interleukin 12B HLA-B major histocompatibility complex, class I, B |
Reports Updated as of Dec 29, 2023 |
PubMed |
| Supravalvar aortic stenosis Autosomal dominant |
•Supravalvular aortic stenosis •SVAS |
Arterial disorders |
ELN elastin |
Reports Updated as of Dec 29, 2023 |
PubMed |
| Situs inversus totalis Autosomal dominant, Autosomal recessive |
•Complete situs inversus |
Visceral heterotaxy |
PKD1L1 polycystin 1 like 1, transient receptor potential channel interacting MNS1 meiosis specific nuclear structural 1 CFAP52 cilia and flagella associated protein 52 NODAL nodal growth differentiation factor |
Reports Updated as of Dec 29, 2023 |
PubMed |
| Hereditary lymphedema type I Autosomal dominant |
•Milroy disease •Congenital hereditary lymphedema •Early onset lymphedema |
Primary lymphedema |
FLT4 fms related receptor tyrosine kinase 4 EPHB4 EPH receptor B4 |
Reports Updated as of Jan 04, 2024 |
PubMed |
| Naxos disease Autosomal recessive |
•Keratosis palmoplantaris with arrythmogenic cardiomyopathy •Mal de Naxos •Arrhythmogenic Right Ventricular Dysplasia |
Inherited arrhythmogenic cardiomyopathy |
JUP junction plakoglobin |
Reports Updated as of Feb 01, 2024 |
PubMed |
| Marfan syndrome Autosomal dominant |
•FBN1-Related Thoracic Aortic Aneurysms and Aortic Dissections •Marfan syndrome type 1 •Marfan syndrome, classic •Marfan's syndrome |
Arterial disorders |
FBN1 fibrillin 1 COL1A2 collagen type I alpha 2 chain LTBP2 latent transforming growth factor beta binding protein 2 TGFBR2 transforming growth factor beta receptor 2 COL5A2 collagen type V alpha 2 chain NOTCH1 notch receptor 1 TGFB2 transforming growth factor beta 2 |
Reports Updated as of Feb 20, 2024 |
PubMed |
| Long QT syndrome Autosomal dominant |
Cardiac arrhythmia |
SCN4B sodium voltage-gated channel beta subunit 4 KCNQ1 potassium voltage-gated channel subfamily Q member 1 AKAP9 A-kinase anchoring protein 9 KCNE2 potassium voltage-gated channel subfamily E regulatory subunit 2 CAV3 caveolin 3 SNTA1 syntrophin alpha 1 KCNJ5 potassium inwardly rectifying channel subfamily J member 5 SCN5A sodium voltage-gated channel alpha subunit 5 KCNE1 potassium voltage-gated channel subfamily E regulatory subunit 1 KCNH2 potassium voltage-gated channel subfamily H member 2 ANK2 ankyrin 2 CALM2 calmodulin 2 CACNA1C calcium voltage-gated channel subunit alpha1 C KCNJ2 potassium inwardly rectifying channel subfamily J member 2 RYR2 ryanodine receptor 2 TRPM4 transient receptor potential cation channel subfamily M member 4 CALM1 calmodulin 1 PKP2 plakophilin 2 CALM3 calmodulin 3 MYPN myopalladin RNF207 ring finger protein 207 CACNA1S calcium voltage-gated channel subunit alpha1 S MYH6 myosin heavy chain 6 MYBPC3 myosin binding protein C3 DSG2 desmoglein 2 CTNNA3 catenin alpha 3 |
Reports Updated as of Feb 20, 2024 |
PubMed | |
| Arterial tortuosity syndrome Autosomal recessive |
•ATS |
Arterial disorders |
SLC2A10 solute carrier family 2 member 10 |
Reports Updated as of Feb 20, 2024 |
PubMed |
| Cardiomyopathy, familial restrictive, 1 Autosomal dominant |
•TNNI3-Related Familial Restrictive Cardiomyopathy |
Cardiogenetic disease |
TNNI3 troponin I3, cardiac type |
Reports Updated as of Feb 01, 2025 |
PubMed |
| Catecholaminergic polymorphic ventricular tachycardia 1 Autosomal dominant, Autosomal recessive |
•Ventricular tachycardia, stress-induced polymorphic 1 •Catecholaminergic polymorphic ventricular tachycardia •bidirectional tachycardia induced by catecholamine •double tachycardia induced by catecholamines •malignant paroxysmal ventricular tachycardia •multifocal ventricular premature beats •ventricular tachycardia, catecholaminergic polymorphic •catecholamine-induced polymorphic ventricular tachycardia •Familial polymorphic ventricular tachycardia •Polymorphic catecholergic ventricular tachycardia •RYR2-related catecholaminergic polymorphic ventricular tachycardia •Stress-induced polymorphic ventricular tachycardia |
Cardiac arrhythmia |
RYR2 ryanodine receptor 2 CASQ2 calsequestrin 2 DSP desmoplakin TRDN triadin |
Reports Updated as of Feb 01, 2025 |
PubMed |
| Arrhythmogenic right ventricular dysplasia 2 Autosomal dominant, Autosomal recessive |
•Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome •ARVC cardiomyopathy •arrhythmogenic right ventricular dysplasia •right ventricular dysplasia |
Cardiac arrhythmia |
RYR2 ryanodine receptor 2 TNNI3K TNNI3 interacting kinase |
Reports Updated as of Feb 01, 2025 |
PubMed |
| Left ventricular noncompaction cardiomyopathy Autosomal dominant, Autosomal recessive, X-linked recessive, MT inheritance |
•LVNC •Left ventricular noncompaction •left ventricular hypertrabeculation •left ventricular non-compaction cardiomyopathy •left ventricular non-compaction syndrome •left ventricular noncompaction (disease) •Lv non-compaction syndrome •LVNC •spongy myocardium |
Congenital heart disease |
MYH7 myosin heavy chain 7 TTN titin RYR2 ryanodine receptor 2 DSP desmoplakin MYBPC3 myosin binding protein C3 SCN5A sodium voltage-gated channel alpha subunit 5 LAMA4 laminin subunit alpha 4 DMD dystrophin LDB3 LIM domain binding 3 ACTC1 actin alpha cardiac muscle 1 DTNA dystrobrevin alpha TAFAZZIN tafazzin, phospholipid-lysophospholipid transacylase TPM1 tropomyosin 1 DSG2 desmoglein 2 TBX5 T-box transcription factor 5 PKP2 plakophilin 2 HCN4 hyperpolarization activated cyclic nucleotide gated potassium channel 4 PRDM16 PR/SET domain 16 RAF1 Raf-1 proto-oncogene, serine/threonine kinase |
Reports Updated as of Feb 01, 2025 |
PubMed |
| Pulmonary arterial hypertension Autosomal dominant |
•PAH |
Arterial disorders |
ACVRL1 activin A receptor like type 1 BMPR2 bone morphogenetic protein receptor type 2 ENG endoglin SMAD9 SMAD family member 9 TBX4 T-box transcription factor 4 ABCA3 ATP binding cassette subfamily A member 3 KCNK3 potassium two pore domain channel subfamily K member 3 EIF2AK4 eukaryotic translation initiation factor 2 alpha kinase 4 ATP13A3 ATPase 13A3 SOX17 SRY-box transcription factor 17 NOTCH1 notch receptor 1 |
Reports Updated as of Feb 26, 2025 |
PubMed |
| Andersen Tawil syndrome Autosomal dominant |
•Long QT syndrome 7 •Andersen-tawil syndrome •Andersen cardiodysrhythmic periodic paralysis •long QT syndrome type 7 •Andersen syndrome •Potassium-sensitive cardiodysrhythmic type •Periodic paralysis, potassium-sensitive cardiodysrhythmic type •Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features •LQT7 |
Congenital heart disease |
KCNJ2 potassium inwardly rectifying channel subfamily J member 2 |
Reports Updated as of Jun 12, 2025 |
PubMed |
| Loeys-Dietz syndrome 2 Autosomal dominant |
•TGFBR2-related thoracic aortic aneurysms and aortic dissections •Loeys-Dietz syndrome caused by mutation in tgfbr2 •Loeys-Dietz syndrome type 2 •Loeys-Dietz syndrome type ii •Marfan like connective tissue disorder •Marfan syndrome type 2 •Marfan syndrome, type 2 (formerly) • MFS 2 •LDS2 •TGFBR2 Loeys-Dietz syndrome •TGFBR2-related Loeys-Dietz syndrome •Aortic aneurysm, familial thoracic 3 •Marfan like connective tissue disorder •Marfan syndrome, type ii |
Vascular disorders |
TGFBR2 transforming growth factor beta receptor 2 TMPO thymopoietin |
Reports Updated as of Jan 05, 2026 |
PubMed |
| Heterotaxy, visceral, 6, autosomal Autosomal recessive |
•HTX6 |
Congenital heart disease |
CFAP53 cilia and flagella associated protein 53 |
Reports Updated as of Mar 30, 2026 |
PubMed |
| Hypertrophic cardiomyopathy 14 Autosomal dominant |
•Cardiomyopathy, Familial Hypertrophic, 14 •CMH14 |
Cardiogenetic disease |
MYH6 myosin heavy chain 6 |
Reports Updated as of Mar 30, 2026 |
PubMed |
| Arterial calcification, generalized, of infancy, 1 Autosomal recessive |
•Arterial calcification of infancy •GACI1 •Generalized arterial calcification of infancy •Idiopathic infantile arterial calcification •Idiopathic obliterative arteriopathy •Infantile arteriosclerosis •Occlusive infantile arteriopathy •Arterial Calcification, Generalized, of Infancy •Arterial calcification, generalized, of infancy, 1(GACI1) |
Arterial disorders |
ENPP1 ectonucleotide pyrophosphatase/phosphodiesterase 1 |
Reports Updated as of Mar 30, 2026 |
PubMed |
| Restrictive cardiomyopathy Autosomal dominant, Autosomal recessive |
•Cardiomyopathies, Restrictive •Cardiomyopathy, Restrictive •Familial Restrictive Cardiomyopathy •Restrictive Cardiomyopathies •Primary restrictive cardiomyopathy •Constrictive cardiomyopathy |
Cardiomyopathy |
TNNT2 troponin T2, cardiac type MYH7 myosin heavy chain 7 TNNI3 troponin I3, cardiac type MYPN myopalladin FLNC filamin C PDLIM3 PDZ and LIM domain 3 TTN titin |
Reports Updated as of Mar 30, 2026 |
PubMed |
| Parkes Weber syndrome Autosomal dominant |
•Capillary malformation-arteriovenous malformation 1 •Cutaneous flush with underlying multiple micro arteriovenous fistulas, soft tissue and skeletal hypertrophy of the affected limb •CMAVM1 •PKWS |
Vascular disorders |
MAP2K1 mitogen-activated protein kinase kinase 1 |
Reports Updated as of Apr 28, 2026 |
PubMed |
| Verrucous hemangioma |
•Verrucous venous malformation |
Vascular disorders |
MAP3K3 mitogen-activated protein kinase kinase kinase 3 |
Reports Updated as of Apr 28, 2026 |
PubMed |
| Angioosteohypertrophic syndrome Autosomal dominant |
•Klippel-Trenaunay syndrome •Angio-osteohypertrophic syndrome •Angioosteohypertrophy syndrome •Haemangiectatic hypertrophy •Klippel Trenaunay syndrome •Klippel-Trenaunay-weber syndrome, isolated cases •Klippel-TrĂ©naunay syndrome •Klippel-TrĂ©naunay-weber syndrome •Weber-Klippel-Trenaunay •KTS •KTW syndrome |
Vascular disorders |
RASA1 RAS p21 protein activator 1 |
Reports Updated as of Apr 28, 2026 |
PubMed |